- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05895357
The Effect of Music Therapy on Comfort, Pain and Anxiety
The Effect of Music Therapy on Comfort, Pain and Anxiety in Patients With Bone Marrow Aspiration and Biopsy: A Randomized Controlled Research
Objectives: This study was conducted to determine the effect of music therapy on the pain, anxiety, and comfort levels of patients who underwent bone marrow aspiration and biopsy.
Methods: This research was conducted as a randomized controlled study in the hematology polyclinic of a university hospital. Music therapy will used with the intervention group throughout the procedure. During data evaluation, paired t-test, independent t-test and effect size will used. The sample group was calculated based on the sample groups of other studies in the literature (Çelebi et al., 2020; Özdemir et al., 2019). According to the preliminary power analysis results using the G.Power 3.1.9 program, the sample size was calculated at 80% power, at medium effect size at 5% alpha value. According to the analysis results, the sample size per group was calculated as 30. However, since there was 10% probability that some patients may drop, the sample size for the study was recalculated as 66 (Experimental Group: 33, Control Group: 33).The patients will informed about using music. In addition, it will explained that they could adjust the sound levels and that they should report when they are disturbed by the tone. Music continued throughout the process. Communication with the patient will maintained, and symptoms such as discomfort, anxiety were observed throughout the procedure. The music player will switched off after the procedure was completed. The patients will asked whether they had any discomfort while the music played. TThe music therapy will last an average of 30 minutes. After completing the procedures, the patient's pain, comfort, and anxiety levels were re-evaluated using VAS and STAI.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kayseri, Turkey, 38000
- Kayseri City Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Clinical diagnosis of hematological malignancy (defined as multiple myeloma, Chronic Lymphocytic Leukaemia, Myelodysplastic syndrome or indolent lymphoma)
- 18 years of age or older,
- Must be able to speak Turkish
Exclusion Criteria:
- Hearing impairment
- hormonal dysfunction (adrenal, pituitary, thyroid, etc.)
- Sever anxiety disorder
- Parkinson's disease
- Alzheimer's disease
- Dementia
- Major depression
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Music Therapy
The patients were asked about the type of music they wanted to listen to.
Especially in the last meta-analyses, it was determined that listening to the music that patients chose was more effective (Witten 2020).
For this reason, after the intervention group is asked about the music they want to listen to, the music they want will be played from the music application.
|
The patients were asked about the type of music they wanted to listen to.
Especially in the last meta-analyses, it was determined that listening to the music that patients chose was more effective (Witten 2020).
For this reason, after the intervention group is asked about the music they want to listen to, the music they want will be played from the music application.
|
No Intervention: No intervention
The patients in the control group will not listen to music, and routine procedures will performed in the clinic without additional intervention.
Anxiety, pain, and comfort assessments will made in the control group patients before and after the procedure.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual Analog Scale (VAS) Pain and Comfort
Time Frame: 10 minutes
|
The scale, used to measure patients' subjective pain and comfort, was developed by Price et al. (1983) (Price et al., 1983).
This scale consists of a 10 cm horizontal or vertical line with both ends representing the minimum and maximum scores for pain and comfort (0: no pain/no discomfort (very comfortable), 10: most severe pain/very uncomfortable (not at all).
Comfort was defined by patients as a pleasant feeling and as the absence of physical discomfort.
The patients will asked to indicate their pain severity and comfort on the scale.
The distance between the indicated point and the lowest endpoint of the line will measured in centimeters using a ruler, and the numeric value will assigned as the individual's pain score.
|
10 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
State Trait Anxiety Scale (STAI)
Time Frame: 10 minutes
|
The inventory consisting 40 items was developed by Spielberger et al. (1983) (Spielberger, 1983).
The STAI consists of two separate scales to assess state (STAI-S) and trait (STAI-T) anxiety.
Öner (1998) performed the Turkish validity and reliability studies of the scale.
In the validity and reliability study of the STAI Turkish form, test-retest reliability coefficients ranged from 0,94 to 0,96 for state anxiety and ranged from 0,83 and 0,87 for trait anxiety.
The State Anxiety Inventory with 20 items (Items 1-20) that assess the respondent's current feelings was used in this study.
Each item is rated on a 4-point Likert scale from 1 (Almost never) to 4 (Almost always).
Subscale scores range from 20 to 80, and higher scores indicate higher anxiety levels
|
10 minutes
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 820
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hematological Malignancy
-
Century Therapeutics, Inc.RecruitingHematological Malignancy | Solid Tumor MalignancyUnited States
-
Henry Ford Health SystemRecruitingHematological MalignancyUnited States
-
SanofiCompletedHematological MalignancyGreece, Spain, Peru, Israel, United States, Argentina, Belgium, Brazil, Chile, Finland, France, Italy, Mexico, Russian Federation, Turkey, Ukraine, United Kingdom
-
University of CopenhagenZealand University HospitalEnrolling by invitationHematological MalignancyDenmark
-
Washington University School of MedicineBarnes-Jewish HospitalTerminatedHematological MalignancyUnited States
-
Institut Paoli-CalmettesCompletedHematological MalignancyFrance
-
Peking University People's HospitalSanofiRecruitingHematological MalignancyChina
-
M.D. Anderson Cancer CenterRecruiting
-
Beckman Coulter, Inc.Completed
-
Fate TherapeuticsTerminatedHematological MalignancyUnited States
Clinical Trials on Musictherapy
-
Universidade Federal de GoiasAssociaçao de Combate ao Cancer em GoiasCompletedBreast Cancer | Ovarian Cancer | Uterine CancerBrazil